293 related articles for article (PubMed ID: 31722658)
1. In vitro Permeability and Bioavailability Enhancement of Curcumin by Nanoemulsion via Pulmonary Administration.
Shi L; Qu Y; Li Z; Fan B; Xu H; Tang J
Curr Drug Deliv; 2019; 16(8):751-758. PubMed ID: 31722658
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
3. Lipid- and Polymer-Based Nanostructures for Cutaneous Delivery of Curcumin.
Caon T; Mazzarino L; Simões CM; Senna EL; Silva MA
AAPS PharmSciTech; 2017 Apr; 18(3):920-925. PubMed ID: 27230504
[TBL] [Abstract][Full Text] [Related]
4. Intravaginal Delivery of Polyphenon 60 and Curcumin Nanoemulsion Gel.
Kaur A; Saxena Y; Bansal R; Gupta S; Tyagi A; Sharma RK; Ali J; Panda AK; Gabrani R; Dang S
AAPS PharmSciTech; 2017 Aug; 18(6):2188-2202. PubMed ID: 28070848
[TBL] [Abstract][Full Text] [Related]
5. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability.
Onoue S; Takahashi H; Kawabata Y; Seto Y; Hatanaka J; Timmermann B; Yamada S
J Pharm Sci; 2010 Apr; 99(4):1871-81. PubMed ID: 19827133
[TBL] [Abstract][Full Text] [Related]
6. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
[TBL] [Abstract][Full Text] [Related]
7. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability.
Parikh A; Kathawala K; Song Y; Zhou XF; Garg S
Drug Deliv Transl Res; 2018 Oct; 8(5):1389-1405. PubMed ID: 29845380
[TBL] [Abstract][Full Text] [Related]
9. Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin.
Wan K; Sun L; Hu X; Yan Z; Zhang Y; Zhang X; Zhang J
Int J Pharm; 2016 May; 504(1-2):80-8. PubMed ID: 27034002
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer.
Gao Y; Li Z; Sun M; Li H; Guo C; Cui J; Li A; Cao F; Xi Y; Lou H; Zhai G
Drug Dev Ind Pharm; 2010 Oct; 36(10):1225-34. PubMed ID: 20545506
[TBL] [Abstract][Full Text] [Related]
11. Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin.
Hou Y; Wang H; Zhang F; Sun F; Xin M; Li M; Li J; Wu X
Int J Nanomedicine; 2019; 14():557-571. PubMed ID: 30666114
[TBL] [Abstract][Full Text] [Related]
12. Improvement of the bioavailability of curcumin by a supersaturatable self nanoemulsifying drug delivery system with incorporation of a hydrophilic polymer: in vitro and in vivo characterisation.
Chen XL; Liang XL; Zhao GW; Zeng QY; Dong W; Ou LQ; Zhang HN; Jiang QY; Liao ZG
J Pharm Pharmacol; 2021 Mar; 73(5):641-652. PubMed ID: 33772289
[TBL] [Abstract][Full Text] [Related]
13. Optimization of novel tocopheryl acetate nanoemulsions for parenteral delivery of curcumin for therapeutic intervention of sepsis.
Shukla P; Dwivedi P; Gupta PK; Mishra PR
Expert Opin Drug Deliv; 2014 Nov; 11(11):1697-712. PubMed ID: 25046368
[TBL] [Abstract][Full Text] [Related]
14. Experimental investigation and oral bioavailability enhancement of nano-sized curcumin by using supercritical anti-solvent process.
Anwar M; Ahmad I; Warsi MH; Mohapatra S; Ahmad N; Akhter S; Ali A; Ahmad FJ
Eur J Pharm Biopharm; 2015 Oct; 96():162-72. PubMed ID: 26241925
[TBL] [Abstract][Full Text] [Related]
15. Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration.
Harigae T; Nakagawa K; Miyazawa T; Inoue N; Kimura F; Ikeda I; Miyazawa T
Int J Nanomedicine; 2016; 11():3009-22. PubMed ID: 27418823
[TBL] [Abstract][Full Text] [Related]
16. Curcumin nanocrystals self-stabilized Pickering emulsion freeze-dried powder: Development, characterization, and suppression of airway inflammation.
Wang X; Liao Z; Zhao G; Dong W; Huang X; Zhou X; Liang X
Int J Biol Macromol; 2023 Aug; 245():125493. PubMed ID: 37348593
[TBL] [Abstract][Full Text] [Related]
17. Critical parameters dictating efficiency of membrane-mediated drug transfer using nanoparticles.
Abbasi S; Kajimoto K; Harashima H
Int J Pharm; 2018 Dec; 553(1-2):398-407. PubMed ID: 30393168
[TBL] [Abstract][Full Text] [Related]
18. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in-vitro/in-vivo evaluation of curcumin nanosuspension with solubility enhancement.
Li X; Yuan H; Zhang C; Chen W; Cheng W; Chen X; Ye X
J Pharm Pharmacol; 2016 Aug; 68(8):980-8. PubMed ID: 27283220
[TBL] [Abstract][Full Text] [Related]
20. Effects of food matrix and probiotics on the bioavailability of curcumin in different nanoformulations.
Han J; Ye T; Liu YH; Chen X; Miao GP
J Sci Food Agric; 2021 Oct; 101(13):5627-5635. PubMed ID: 33713049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
